Illumina shareholders oust board chair, CEO survives Carl Icahn proxy battle

Visits: 3

Carl Icahn has accused Illumina’s management and board of poor oversight, particularly with regard to the company’s acquisition of cancer test maker Grail. Read More Go To Source